NFATc1 as a therapeutic target in FLT3-ITD-positive AMLStephan Metzelder, Andreas Burchert, Christian Michel et al.|Leukemia|2015Cited by 52
Prevalence of resistance-associated substitutions and retreatment of patients failing a glecaprevir/pibrentasvir regimenAdolfo de Salazar, Eiko Schnaitmann, Nicola Coppola et al.|Journal of Antimicrobial Chemotherapy|2020Cited by 22
Singh et al EMBO J 2015Shiv K. Singh, Volker Ellenrieder, Nai‐Ming Chen et al.|Unknown|2015Cited by 0